Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer

This study is looking into a modern way to treat prostate cancer using radiation. Imagine radiation treatment like shining a light on the cancer cells to destroy them. Historically, this light was shone in many small doses over a long period. More recently, doctors have started using fewer, larger doses, which is called 'hypofractionated' treatment. This study is taking it a step further with 'ultrahypofractionated' treatment – even fewer, but bigger doses.

The exciting part is the special machine used in this study. It's called an online-adaptive radiotherapy device. This means it's super smart! Every day before your treatment, it takes a look at your body. Because things inside your body can shift slightly, the machine can automatically adjust the radiation plan to make sure the treatment hits its target perfectly and avoids healthy tissue. This daily adjustment is hoped to make the treatment more precise and potentially reduce side effects.

The main goal of the study is to see how well patients get along with this new treatment (its 'tolerability') and how it affects their daily lives, often called 'quality of life'. Researchers will ask patients to fill out questionnaires on a digital device to track their feelings and experiences over time. They will then compare these results with information from patients who had the older, more traditional radiation treatments to see if this new method offers benefits in terms of comfort and well-being.